GB1380009A - Cyclic derivatives of 1,4-benzene disulphonamide - Google Patents

Cyclic derivatives of 1,4-benzene disulphonamide

Info

Publication number
GB1380009A
GB1380009A GB3772072A GB3772072A GB1380009A GB 1380009 A GB1380009 A GB 1380009A GB 3772072 A GB3772072 A GB 3772072A GB 3772072 A GB3772072 A GB 3772072A GB 1380009 A GB1380009 A GB 1380009A
Authority
GB
United Kingdom
Prior art keywords
methoxypiperidinosulphonyl
pharmaceutically acceptable
alkylene
formula
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3772072A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER Ltd
Original Assignee
PFIZER Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER Ltd filed Critical PFIZER Ltd
Priority to GB3772072A priority Critical patent/GB1380009A/en
Priority to IE1344/73A priority patent/IE38177B1/xx
Priority to DE19732340010 priority patent/DE2340010A1/de
Priority to AT691573A priority patent/AT331248B/de
Priority to BE134373A priority patent/BE803373A/xx
Priority to NL7311000.A priority patent/NL162641C/xx
Priority to US386854A priority patent/US3867390A/en
Priority to AU59084/73A priority patent/AU5908473A/en
Priority to LU68211A priority patent/LU68211A1/xx
Priority to CA178,508A priority patent/CA978945A/en
Priority to SE7310996A priority patent/SE385008B/xx
Priority to ZA735474A priority patent/ZA735474B/xx
Priority to FR7329377A priority patent/FR2195449B1/fr
Priority to JP48090450A priority patent/JPS59508B2/ja
Priority to ES417806A priority patent/ES417806A1/es
Priority to IN1864/CAL/73A priority patent/IN139006B/en
Priority to US05/512,012 priority patent/US3932649A/en
Priority to US05/512,008 priority patent/US3974155A/en
Priority to US05/512,009 priority patent/US3957796A/en
Publication of GB1380009A publication Critical patent/GB1380009A/en
Priority to JP56116291A priority patent/JPS5857431B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/10—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B31/00—Disazo and polyazo dyes of the type A->B->C, A->B->C->D, or the like, prepared by diazotising and coupling
    • C09B31/02—Disazo dyes
    • C09B31/12—Disazo dyes from other coupling components "C"
    • C09B31/14—Heterocyclic components

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GB3772072A 1972-08-12 1972-08-12 Cyclic derivatives of 1,4-benzene disulphonamide Expired GB1380009A (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GB3772072A GB1380009A (en) 1972-08-12 1972-08-12 Cyclic derivatives of 1,4-benzene disulphonamide
IE1344/73A IE38177B1 (en) 1972-08-12 1973-08-07 Cyclic derivatives of 1,4-benzene disulphonamide
DE19732340010 DE2340010A1 (de) 1972-08-12 1973-08-07 Cyclische, n-substituierte 1,4benzoldisulfonamid-derivate
AT691573A AT331248B (de) 1972-08-12 1973-08-07 Verfahren zur herstellung von neuen cyclischen, n-substituierten 1,4-benzoldisulfonamid-derivaten und ihren salzen
BE134373A BE803373A (fr) 1972-08-12 1973-08-08 Nouveaux derives de 1,4-benzene-disulfamide et composition pharmaceutique les contenant
NL7311000.A NL162641C (nl) 1972-08-12 1973-08-09 Werkwijze ter bereiding van een farmaceutisch preparaat op basis van een in de benzeenkern gesubstitueerde 4-(heterocyclosulfonyl)-benzeensulfonamide, aldus ver- vaardigde gevormde farmaceutische preparaten, en werk- wijze ter bereiding van in de benzeenkern gesubstitueer- de 4-(heterocyclosulfonyl)-benzeensulfonamiden.
US386854A US3867390A (en) 1972-08-12 1973-08-09 2 and 3-substituted-4-(heterocyclic-amino-sulfonyl)benzene sulfonamides
AU59084/73A AU5908473A (en) 1972-08-12 1973-08-09 2 and 3 substituted-4-heterocyclic amino-sulfonyl benzene sulfonamides as cerebral vasodilators
CA178,508A CA978945A (en) 1972-08-12 1973-08-10 Process for preparing 2 and 3 substituted-4-heterocyclic amino-sulfonyl benzene sulfonamides as cerebral vasodilators
LU68211A LU68211A1 (enExample) 1972-08-12 1973-08-10
SE7310996A SE385008B (sv) 1972-08-12 1973-08-10 Sett att framstella cykliskt n-substituerade derivat av 1,4- bensendisulfonamidderivat
ZA735474A ZA735474B (en) 1972-08-12 1973-08-10 2 and 3 substituted-4-heterocyclic aminosulfonyl benzene sulfonamides as vasodilators
FR7329377A FR2195449B1 (enExample) 1972-08-12 1973-08-10
JP48090450A JPS59508B2 (ja) 1972-08-12 1973-08-11 ノウケツカンカクチヨウザイ ２ ３− チカン −４− フクソカンジヨウアミノスルホニルベンゼンスルホンアミド ノ セイホウ
ES417806A ES417806A1 (es) 1972-08-12 1973-08-11 Procedimiento para la obtencion de derivados de 1,4-bence- no-disulfonamida.
IN1864/CAL/73A IN139006B (enExample) 1972-08-12 1973-08-13
US05/512,012 US3932649A (en) 1972-08-12 1974-10-04 2 And 3-substituted-4-(heterocyclic-amino-sulfonyl)benzene sulfonamides as cerebral vasodilators
US05/512,008 US3974155A (en) 1972-08-12 1974-10-04 2 AND 3-Substituted-4-(heterocyclic-amino-sulfonyl)benzene sulfonamides
US05/512,009 US3957796A (en) 1972-08-12 1974-10-04 2 and 3-substituted-4-(heterocyclic-amino-sulfonyl)benzene sulfonamides
JP56116291A JPS5857431B2 (ja) 1972-08-12 1981-07-24 脳血管拡張剤２，３−置換−４−複素環状アミノスルホニルベンゼンスルホンアミドの製法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3772072A GB1380009A (en) 1972-08-12 1972-08-12 Cyclic derivatives of 1,4-benzene disulphonamide

Publications (1)

Publication Number Publication Date
GB1380009A true GB1380009A (en) 1975-01-08

Family

ID=10398552

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3772072A Expired GB1380009A (en) 1972-08-12 1972-08-12 Cyclic derivatives of 1,4-benzene disulphonamide

Country Status (16)

Country Link
US (1) US3867390A (enExample)
JP (2) JPS59508B2 (enExample)
AT (1) AT331248B (enExample)
AU (1) AU5908473A (enExample)
BE (1) BE803373A (enExample)
CA (1) CA978945A (enExample)
DE (1) DE2340010A1 (enExample)
ES (1) ES417806A1 (enExample)
FR (1) FR2195449B1 (enExample)
GB (1) GB1380009A (enExample)
IE (1) IE38177B1 (enExample)
IN (1) IN139006B (enExample)
LU (1) LU68211A1 (enExample)
NL (1) NL162641C (enExample)
SE (1) SE385008B (enExample)
ZA (1) ZA735474B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4450877A (en) * 1977-11-03 1984-05-29 Hoechst Aktiengesellschaft Pharmaceutical preparations in solid unit dosage form

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070361A (en) * 1977-04-21 1978-01-24 E. R. Squibb & Sons, Inc. Mercaptoalkylsulfonyl proline and pipecolic acid and esters thereof
DE2720654A1 (de) * 1977-05-07 1978-11-16 Bayer Ag Azolyl-alkancarbonsaeure-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
JPS5922023A (ja) * 1982-07-27 1984-02-04 Hoya Corp ビ−ムスプリツタ−

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3165550A (en) * 1960-06-29 1965-01-12 Pfizer & Co C N-substituted p-benzenedisulfonamides

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4450877A (en) * 1977-11-03 1984-05-29 Hoechst Aktiengesellschaft Pharmaceutical preparations in solid unit dosage form

Also Published As

Publication number Publication date
US3867390A (en) 1975-02-18
AT331248B (de) 1976-08-10
IE38177L (en) 1974-02-12
JPS4985066A (enExample) 1974-08-15
JPS5857431B2 (ja) 1983-12-20
NL162641B (nl) 1980-01-15
IE38177B1 (en) 1978-01-18
LU68211A1 (enExample) 1975-05-21
CA978945A (en) 1975-12-02
NL7311000A (enExample) 1974-02-14
IN139006B (enExample) 1976-04-24
JPS59508B2 (ja) 1984-01-07
SE385008B (sv) 1976-05-31
BE803373A (fr) 1974-02-08
ATA691573A (de) 1975-11-15
AU5908473A (en) 1975-02-13
FR2195449B1 (enExample) 1977-09-09
ZA735474B (en) 1974-08-28
FR2195449A1 (enExample) 1974-03-08
DE2340010A1 (de) 1974-03-14
JPS57131774A (en) 1982-08-14
ES417806A1 (es) 1976-03-01
NL162641C (nl) 1980-06-16

Similar Documents

Publication Publication Date Title
RU92004336A (ru) Водорастворимые производные камптотецина, способ их получения, фармацевтическая композиция, способ ингибирования энзима топоизомеразы, промежуточные продукты
LV10456A (lv) Triazolpiridazina atvasinajumi to iegusanas panemiens un pielietojums
GB1489280A (en) Indazole derivatives
AU591390B2 (en) Arylcyclobutylalkyl amines and their use as antidepressive medicines
ES8307760A1 (es) Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina.
GB1380009A (en) Cyclic derivatives of 1,4-benzene disulphonamide
GB1392100A (en) Insecticides
GB1374299A (en) Derivatives of 1,2,3,4-tetrahydroisoquinoline production of the same and composition thereof
ATE174916T1 (de) Imidazopyridazine als antiasthmatika
IE44014L (en) Amino-benzocycloheptenes.
GB1277227A (en) Aryl esters
ES472440A1 (es) Procedimiento para fabricar derivados de 1,3-difenoxipropan -27ona.
GB1410853A (en) Pharmaceutically useful prostaglandin derivatives
GB1361863A (en) Piperazine derivatives their preparation and pharmaceutical compositions containing them
GB1394791A (en) Diphenylalkyllactamimide derivatives
GB1465769A (en) Carbamates of ergolines
GB1393979A (en) Piperidine derivatives
GB1295040A (enExample)
IE35570B1 (en) Pyrimido isoquinolines
GB1346953A (en) Process for the preparation of substituted carbamates
GB1327640A (en) Basically substituted
SE7710697L (sv) Forfarande for framstellning av cefemderivat
GB1489724A (en) Thiazole-5-methanol derivatives
GB1295240A (enExample)
SE7713779L (sv) Nya fenylderivat

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee